These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28480310)

  • 1. Genetic Engineering and Manufacturing of Hematopoietic Stem Cells.
    Wang X; Rivière I
    Mol Ther Methods Clin Dev; 2017 Jun; 5():96-105. PubMed ID: 28480310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug.
    Ferrua F; Aiuti A
    Hum Gene Ther; 2017 Nov; 28(11):972-981. PubMed ID: 28847159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy and genome editing for primary immunodeficiency diseases.
    Zhang ZY; Thrasher AJ; Zhang F
    Genes Dis; 2020 Mar; 7(1):38-51. PubMed ID: 32181274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
    Sauer AV; Di Lorenzo B; Carriglio N; Aiuti A
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):527-34. PubMed ID: 25207699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for inherited immunodeficiency.
    Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
    Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
    Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years of gene therapy for primary immune deficiencies.
    Aiuti A; Roncarolo MG
    Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
    Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
    Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
    Smogorzewska EM; Weinberg KI; Kohn DB
    Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.
    Doering CB; Archer D; Spencer HT
    Adv Drug Deliv Rev; 2010 Sep; 62(12):1204-12. PubMed ID: 20869414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene delivery to hematopoietic stem cells using lentiviral vectors.
    Miyoshi H
    Methods Mol Biol; 2004; 246():429-38. PubMed ID: 14970608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
    Onodera M; Nelson DM; Sakiyama Y; Candotti F; Blaese RM
    Acta Haematol; 1999; 101(2):89-96. PubMed ID: 10202239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tale of two SCIDs.
    Shaw KL; Kohn DB
    Sci Transl Med; 2011 Aug; 3(97):97ps36. PubMed ID: 21865536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
    Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M
    Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of primary T cell immunodeficiencies.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hurdles Associated with the Translational Use of Genetically Modified Cells.
    Raikar SS; Spencer HT
    Curr Stem Cell Rep; 2018 Mar; 4(1):39-45. PubMed ID: 33381387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced Pluripotent Stem Cell Meets Severe Combined Immunodeficiency.
    Kouchaki R; Abd-Nikfarjam B; Maali AH; Abroun S; Foroughi F; Ghaffari S; Azad M
    Cell J; 2020 Jul; 22(suppl 1):1-10. PubMed ID: 32779449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side.
    Garcia-Perez L; Ordas A; Canté-Barrett K; Meij P; Pike-Overzet K; Lankester A; Staal FJT
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.
    Migliavacca M; Assanelli A; Ponzoni M; Pajno R; Barzaghi F; Giglio F; Ferrua F; Frittoli M; Brigida I; Dionisio F; Nicoletti R; Casiraghi M; Roncarolo MG; Doglioni C; Peccatori J; Ciceri F; Cicalese MP; Aiuti A
    Front Immunol; 2018; 9():113. PubMed ID: 29456531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.